p53 is the most commonly mutated gene in human cancers. Recently, two related genes, p73 and p63, have been described which are capable of transactivation and cell-death inducing activities typically associated with the p53 tumor suppressor. Nevertheless, the physiological functions of either gene remain largely unknown. This is a proposal to uncover the function of the p63 gene, and its potential role in processes of cell growth regulation, mammalian development, and tumorigenesis. Importantly, p63 is highly expressed in the basal, or proliferative, cell populations of a wide range of epithelial tissues that are frequent sites of carcinoma in humans. These include skin, cervical and urogenital, epithelia, as well as the prostate and breast. As one means of probing p63 function, we have analyzed the effects of targeted disruptions of this gene in mice. These mice show profound defects in all squamous epithelial, as well as dramatic limb and craniofacial abnormalities. The analysis of p63 is complicated by the existence of multiple isotypes that exhibit strikingly different properties. One class of p63 proteins show functional similarities to p53, while the other appears to have opposite, even dominant-negative activities. An important goal in this proposal is to distinguish these p63 isotypes and determine their physiological significance using murine models. A second focus is to understand the mechanistic basis of p64's essential role, evident from our p63-deficient mice, in regulating the proliferative capacity and differentiation of epithelial cells. Thirdly, as p53 function is tightly controlled by its protein stability and post-translational mechanisms, we will determine if similar mechanisms regulate p64. Finally, we will use differential expression assays to identify target genes of transactivating and suppressing p63 isotypes. We anticipate that the proposed studies will yield new insights toward the function of p63 in regulating epithelial cell proliferation and maturation, and its role in development and tumorigenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA083944-01
Application #
6031212
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Gallahan, Daniel L
Project Start
2000-02-09
Project End
2005-01-31
Budget Start
2000-02-09
Budget End
2001-01-31
Support Year
1
Fiscal Year
2000
Total Cost
$369,873
Indirect Cost
Name
Harvard University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Crum, Christopher P; McKeon, Frank D; Xian, Wa (2012) The oviduct and ovarian cancer: causality, clinical implications, and ""targeted prevention"". Clin Obstet Gynecol 55:24-35
Kumar, Pooja A; Hu, Yuanyu; Yamamoto, Yusuke et al. (2011) Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147:525-38
Yang, Annie; Zhu, Zhou; Kettenbach, Arminja et al. (2010) Genome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo. PLoS One 5:e11572
Lee, Y; Miron, A; Drapkin, R et al. (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211:26-35
Yang, Annie; Zhu, Zhou; Kapranov, Philipp et al. (2006) Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 24:593-602